BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35500744)

  • 21. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 22. Healthcare associated
    Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
    Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
    [No Abstract]   [Full Text] [Related]  

  • 23. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    Tydeman F; Craine N; Kavanagh K; Adams H; Reynolds R; McClure V; Hughes H; Hickman M; Robertson C
    J Antimicrob Chemother; 2021 Aug; 76(9):2437-2445. PubMed ID: 34151964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
    Endo K; Mizuno K; Takeuchi M; Kawakami K
    Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridioides difficile Infection in Children: The Role of Infection Prevention and Antimicrobial Stewardship.
    Savage TJ; Sandora TJ
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S64-S68. PubMed ID: 34791402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Our experience with 80 cases of SARS-CoV-2-Clostridioides difficile co-infection: An observational study.
    Birlutiu V; Dobritoiu ES; Lupu CD; Herteliu C; Birlutiu RM; Dragomirescu D; Vorovenci A
    Medicine (Baltimore); 2022 Jul; 101(27):e29823. PubMed ID: 35801777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?
    Lewandowski K; Rosołowski M; Kaniewska M; Kucha P; Meler A; Wierzba W; Rydzewska G
    Pol Arch Intern Med; 2021 Feb; 131(2):121-127. PubMed ID: 33314875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of healthcare-associated Clostridioides difficile infections and association with ward-level antibiotic consumption in a German university hospital: an ecological study.
    Kipnis M; Schwab F; Kramer TS; Stegemann MS; Isner C; Pilarski G; Märtin N; Bui MT; Boldt AC; Behnke M; Denkel LA; Wiese-Posselt M; Zweigner J; Gastmeier P; Rohde AM
    J Antimicrob Chemother; 2019 Aug; 74(8):2400-2404. PubMed ID: 31098633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between consumption of antibiotics, infection control interventions and Clostridioides difficile infections: Analysis of six-year time-series data in a tertiary-care hospital in Greece.
    Papanikolopoulou A; Maltezou HC; Gargalianos-Kakolyris P; Pangalis A; Pantazis N; Pantos C; Tountas Y; Tsakris A; Kantzanou M
    Infect Dis Health; 2022 Aug; 27(3):119-128. PubMed ID: 35153189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia.
    O'Leary AL; Chan AK; Wattengel BA; Xu J; Mergenhagen KA
    Am J Infect Control; 2024 Mar; 52(3):280-283. PubMed ID: 37921728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Bio-K+ for the prevention of
    Leal J; Shen Y; Faris P; Dalton B; Sabuda D; Ocampo W; Bresee L; Chow B; Fletcher JR; Henderson E; Kaufman J; Kim J; Raman M; Kraft S; Lamont NC; Larios O; Missaghi B; Holroyd-Leduc J; Louie T; Conly J
    Infect Control Hosp Epidemiol; 2024 Apr; 45(4):443-451. PubMed ID: 38073551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis.
    Granata G; Petrosillo N; Al Moghazi S; Caraffa E; Puro V; Tillotson G; Cataldo MA
    Anaerobe; 2022 Apr; 74():102484. PubMed ID: 34843959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-Discharge
    Jachowicz E; Pac A; Różańska A; Gryglewska B; Wojkowska-Mach J
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328843
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings.
    Conlon-Bingham GM; Aldeyab M; Scott M; Kearney MP; Farren D; Gilmore F; McElnay J
    Emerg Infect Dis; 2019 Jan; 25(1):52-62. PubMed ID: 30561306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring Clostridium difficile infection in an acute hospital: prevalence or incidence studies?
    Lavan AH; McCartan DP; Downes MM; Hill AD; Fitzpatrick F
    Ir J Med Sci; 2012 Sep; 181(3):315-20. PubMed ID: 22350440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.
    de Blank P; Zaoutis T; Fisher B; Troxel A; Kim J; Aplenc R
    J Pediatr; 2013 Sep; 163(3):699-705.e1. PubMed ID: 23477996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A decade of Clostridioides difficile infection: a constant challenge to maintain the status quo.
    Skally M; Bennett K; Burns K; Brennan R; Finn C; O'Connell K; Dinesh B; O'Donnell S; Fawley W; Wilcox M; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2023 May; 135():59-66. PubMed ID: 36863458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.
    Kovačević N; Lendak D; Popović M; Plećaš Đuric A; Pete M; Petrić V; Sević S; Tomić S; Alargić J; Damjanov D; Kosjer D; Lekin M
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143939
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.